These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19531900)

  • 21. Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
    Yang SC; Fu NK; Zhang J; Liang M; Cong HL; Lin WH; Tian FS; Lu CZ; Sun TT; Zhang WY; Ma ZH
    Angiology; 2018 May; 69(5):393-399. PubMed ID: 29073785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization.
    Saito Y; Watanabe M; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
    Circ J; 2015; 79(7):1624-30. PubMed ID: 25891891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography.
    Mitchell AM; Jones AE; Tumlin JA; Kline JA
    Acad Emerg Med; 2012 Jun; 19(6):618-25. PubMed ID: 22687176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
    Chen Y; Hu S; Liu Y; Zhao R; Wang L; Fu G; He Q; Su X; Zheng Y; Qi X; Liu H; Wang J; Gao W; Wang M; Liu S; Zheng X; He B; Yang P; Zhou S; Gao C; Qiu C
    EuroIntervention; 2012 Nov; 8(7):830-8. PubMed ID: 23045301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.
    Gao YM; Li D; Cheng H; Chen YP
    Clin Exp Nephrol; 2014 Dec; 18(6):892-8. PubMed ID: 24515307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between contrast-induced nephrotoxicity and contrast enhanced computed tomography followed by endoscopic retrograde cholangiopancreatography.
    Shinoura S; Tokushige A; Chinen K; Mori H; Kato S; Ueda S
    Eur J Radiol; 2020 Aug; 129():109074. PubMed ID: 32473539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
    Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
    Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography.
    Chen SQ; Liu Y; Smyth B; Li HL; Sun GL; Chen ZJ; Zhou YL
    Heart Lung Circ; 2019 Jun; 28(6):866-873. PubMed ID: 29960836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
    Kim SM; Cha RH; Lee JP; Kim DK; Oh KH; Joo KW; Lim CS; Kim S; Kim YS
    Am J Kidney Dis; 2010 Jun; 55(6):1018-25. PubMed ID: 20097462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization.
    Shukla AN; Juneja M; Patel H; Shah KH; Konat A; Thakkar BM; Madan T; Prajapati J
    Indian Heart J; 2017; 69(3):311-315. PubMed ID: 28648419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inferior vena cava assessment can predict contrast-induced nephropathy in patients undergoing cardiac catheterization: A single-center prospective study.
    Gungoren F; Besli F; Tanriverdi Z; Demirbag R
    Echocardiography; 2018 Dec; 35(12):1915-1921. PubMed ID: 30303247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there an association between non-steroidal anti-inflammatory drugs and contrast nephropathy?
    Diogo LP; Saitovitch D; Biehl M; Bahlis LF; Guterres MC; O'Keeffe CF; Carvalhal GF; Caramori PR
    Arq Bras Cardiol; 2010 Dec; 95(6):726-31. PubMed ID: 21109911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.
    Kafkas N; Liakos C; Zoubouloglou F; Dagadaki O; Dragasis S; Makris K
    Clin Cardiol; 2016 Aug; 39(8):464-70. PubMed ID: 27175937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of N-terminal pro-B-type natriuretic peptide with contrast-induced nephropathy and long-term outcomes in patients with chronic kidney disease and relative preserved left ventricular function.
    Liu YH; Liu Y; Zhou YL; Yu DQ; He PC; Xie NJ; Li HL; Wei-Guo ; Chen JY; Tan N
    Medicine (Baltimore); 2015 Apr; 94(13):e358. PubMed ID: 25837748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention.
    Abe M; Morimoto T; Akao M; Furukawa Y; Nakagawa Y; Shizuta S; Ehara N; Taniguchi R; Doi T; Nishiyama K; Ozasa N; Saito N; Hoshino K; Mitsuoka H; Toma M; Tamura T; Haruna Y; Kita T; Kimura T
    Am J Cardiol; 2014 Aug; 114(3):362-8. PubMed ID: 24927973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.
    Harjai KJ; Raizada A; Shenoy C; Sattur S; Orshaw P; Yaeger K; Boura J; Aboufares A; Sporn D; Stapleton D
    Am J Cardiol; 2008 Mar; 101(6):812-9. PubMed ID: 18328846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.